VCST yields 1000000.00% · JNJ yields 2.14%● Live data
📍 VCST pulled ahead of the other in Year 1
Combined, VCST + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCST + JNJ for your $10,000?
ViewCast.com, Inc., doing business as ViewCast Corporation, develops hardware and software for the capture, management, and delivery of video over IP and mobile networks. The company's products include Osprey Video line of capture cards for video acquisition/capture/streaming; and Niagara Streaming Systems and Software, which provide pre-configured, plug-and-play solutions enabling the user to encode and stream audio and video over the Internet or corporate network. It also provides professional services and support; and complementary products and technologies from third party providers. The company serves various markets, including broadcasters, content delivery networks, and narrowcasters; federal, state, and local governments; small, medium, and large enterprises; mobile and cable providers; education and training; retail and consumer package goods; digital signage integrators; and other industry verticals, such as advertising, medical, and insurance. ViewCast.com, Inc. markets and sells its products and professional services directly to end-users or through indirect channels comprising original equipment manufacturers, value-added resellers, resellers, distributors, and computer system integrators worldwide. The company was formerly known as MultiMedia Access Corporation and changed its name to ViewCast.com, Inc. in April 1999. ViewCast.com, Inc. was founded in 1994 and is headquartered in Plano, Texas.
Full VCST Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.